Clinical Trial Update: Dexmedetomidine Adjuvant Treatment for Depressed Patients Undergoing ECT [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating dexmedetomidine as an adjuvant treatment for patients with depressive disorders undergoing electroconvulsive therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Sultan Qaboos University | Conditions: Depressive Disorder, Major | Phase 4 | Status: UNKNOWN